Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Monoclonal Antibody Against Sortilin Induces Apoptosis in Human Breast Cancer Cells Publisher



Simonian M1 ; Ghaffari MH1 ; Salimi A2 ; Mirzadegan E3 ; Sadeghi N2 ; Ebrahimnezhad N2 ; Fazli G2 ; Fatemi R2 ; Bayat AA2 ; Milani S4 ; Negahdari B1 ; Rabbani H2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of edical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
  3. 3. Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
  4. 4. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran

Source: Avicenna Journal of Medical Biotechnology Published:2022


Abstract

Background: Sortilin has an important role in various malignances and can be used as a promising target to eradicate cancer cells. Methods: In this study, the expression of sortilin in 4T1 and MDA-MB231 cell lines was evaluated by flow cytometry and immunocytochemistry. Apoptosis assay was also applied to evaluate apoptosis induction in 4T1 and MDA-MB231 cell lines. Results: Based on cell surface flow cytometry results, anti-sortilin (2D8-E3) mAb could recognize sortilin molecules in 79.2% and 90.3% of 4T1 and MDA-MB231 cell-lines, respectively. The immunocytochemistry staining results confirmed sortilin surface expression. Apoptosis assay indicated that anti-sortilin mAb could induce apoptosis in 4T1 and MDA-MB231 cell lines. Conclusion: Our study revealed the important role of surface sortilin in breast carcinoma cell survival and its possible application as a therapeutic agent in cancer targeted therapies. © 2022, Avicenna Journal of Medical Biotechnology. All rights reserved.